Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cerebral Hyperperfusion after Carotid Artery Stenting
033
Authors/Disclosures
No disclosure on file
Luigi Lavorgna Luigi Lavorgna has nothing to disclose.
Daniel Kantor, MD, FAAN (Medical Partnership 4 MS+) Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas, LLC. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Osmotica Pharmaceuticals. The institution of Dr. Kantor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Kantor has received research support from Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to AAN interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to AAN interests or activities.